newsgeriatric oncologyhead and neck cancer
Rethinking the Standard: Does Less Mean More for Frail Elderly Patients with Head and Neck Cancer?
By MedXY|Mar 2, 2026
The ELAN-RT trial demonstrates that hypofractionated split-course radiotherapy is non-inferior to standard fractionation for 6-month locoregional response in frail older patients, providing a less toxic alternative, though standard therapy
